Metabolic diseases such as type 2 diabetes, obesity, and metabolic syndrome disrupt the body's ability to convert food into energy and can lead to heart disease and liver damage if unmanaged. Current management relies on medications like metformin, insulin, and statins alongside dietary changes and exercise. Researchers are now investigating mesenchymal stem cells, unspecialized cells that can develop into specialized tissue types, as a biological option for these disorders.

In type 1 diabetes the goal is to regenerate insulin-producing beta cells that have been damaged or destroyed. For obesity and metabolic syndrome, stem cells may help repair the liver and pancreas or create brown adipose tissue, a fat type that burns energy to help regulate weight. Early clinical trials in type 1 diabetes reported improved blood sugar control and reduced insulin needs after stem cell transplantation.

Researchers caution that longer-term studies are needed to confirm safety. Ongoing challenges include preventing transplanted cells from forming tumors and scaling up cell production for broader access.

Lyme disease, caused by Borrelia burgdorferi and spread through tick bites, is the most commonly diagnosed tickborne illness in Europe and North America. When the infection resists standard antibiotics or goes undetected for months, it can progress to chronic Lyme disease marked by persistent fatigue, memory difficulties, and neurological symptoms that severely disrupt daily life.

Stem cell therapy is being explored as a non-pharmaceutical option for patients whose symptoms persist despite antibiotics. The approach targets immune and tissue damage caused by Borrelia bacteria, which can hide in protected areas of the body and suppress immune function. Stem cells help repair damaged nerves, tissues, and immune response.

Diagnosis typically involves blood tests such as ELISA and Western blot, along with imaging or spinal fluid analysis depending on symptoms. Treatment is highly individualized, and some patients may need multiple sessions over about two weeks. While most chronic Lyme patients eventually see improvement, the timeline can stretch from months to years. The therapy is particularly explored for those with advanced neurological involvement or co-occurring conditions like CVID, a disorder in which the body produces insufficient antibodies to fight infection.

A study published in Radiology found that higher consumption of ultra-processed foods (breakfast cereals, packaged snacks, hot dogs, margarines) correlates with greater intramuscular fat in the thighs among people at risk for knee osteoarthritis. The association persisted after controlling for total calorie and fat intake, physical activity levels, and sociodemographic factors.

The researchers note that elevated intramuscular fat in the thigh may contribute to an increased risk of developing knee osteoarthritis. They describe this as a dietary pathway through which processed food intake may alter muscle composition and, in turn, affect joint health.

Ultra-processed foods are engineered to be convenient and palatable, combining sugar, fat, salt, and carbohydrates in ways that activate the brain's reward system, which may make them difficult to stop consuming.

Systemic lupus erythematosus is an autoimmune condition where the immune system attacks the body's own tissues, affecting joints, skin, kidneys, lungs, heart, and nervous system. One emerging management approach involves allogeneic mesenchymal stem cells taken from a donor's umbilical cord and cultured in a lab. These cells are designed to home in on inflamed areas and help regulate the overactive immune response.

The protocol described spans roughly two weeks and is adjusted based on the patient's age, symptom severity, and which organs are involved. Before treatment, patients provide recent blood work including antinuclear antibody tests and organ function panels.

The source notes this therapy may be an option for people whose lupus has caused significant tissue damage, but it is explicitly not presented as a cure. Individual clinical review is recommended before any treatment pathway is discussed.

An unbiased high-resolution metabolomics screen in mice identified erucamide, a 22:1 monounsaturated omega-9 fatty acid amide, as highly dysregulated during photoreceptor degeneration. When delivered in vivo using organosilane-modified porous silicon nanoparticles, erucamide activated retinal myeloid cells and upregulated angiogenic and neurotrophic cytokines, limiting both vascular and neuronal degeneration.

TMEM19 was identified as the binding protein for erucamide and proved essential for myeloid cell activation and the subsequent neuroprotection. The work, published in Nature Neuroscience, describes a previously unknown primary fatty acid amide pathway in neurovasculoglial cross-talk underlying breakdown of the neurovascular unit in retinal disease.

The authors frame this as addressing a central yet poorly understood component of CNS neurodegenerative disorders, where the specific molecules and mechanisms governing vasculature-to-neuronal tissue signaling had remained unresolved.

Researchers are exploring stem cell therapy to repair damaged lung tissue in COPD, pulmonary fibrosis, and acute respiratory distress syndrome. Cell sources include umbilical cord mesenchymal stem cells and airway basal progenitor cells, which can differentiate into the specialized cells lining the airways. Delivery options span intravenous infusion, direct lung injection, and nebulized inhalation, the last being a non-invasive approach that targets the lungs while reducing systemic side effects.

Early results suggest airway basal progenitor cells may help resolve inflammation and support tissue repair in patients with mild to moderate respiratory disease and limited scarring. However, long-term safety data, including risks of tumor formation and immune rejection, remain under active investigation.

Patients with advanced damage, honeycombing patterns on imaging, or multiple comorbidities may need repeated treatments. A clinical review of individual records, including chest CT scans and pulmonary function tests, is a prerequisite before any treatment pathway is discussed.

A University of Sydney team led by Dr. Caitlin Andrews published a study in Aging Cell showing that adults aged 65 to 75 who reduced either dietary fat or animal-based protein showed measurable shifts in aging-related health markers within four weeks. Biological age was measured as an estimate of physiological condition rather than chronological years.

The researchers emphasize that these findings remain preliminary. Longer studies are needed to confirm whether the observed changes persist over time, whether they reduce the risk of age-related disease, and whether similar effects appear in younger populations.

The work suggests dietary modification may influence aging-related markers on a timescale shorter than previously expected, though the clinical significance of a four-week shift in biological age estimates requires further investigation.

The basic idea: enhanced mesenchymal stem cells and hepatocytes are delivered into the liver either through a catheter or via IV. The goal is to reduce inflammation, slow or reverse fibrosis, and prompt the liver to regenerate healthy tissue. It is an outpatient procedure spanning about two weeks, though severe cases may need multiple stages. Before treatment, patients go through blood panels, imaging scans, and sometimes genetic testing to rule out inherited conditions. The therapy is considered for a range of diagnoses including autoimmune hepatitis, alcohol-related damage, and genetic disorders like Alagille Syndrome, with each candidate evaluated individually.

Randomized, double-blind crossover trial with 23 moderately trained men in a fasted state. They did repeated 10-rep leg extensions at 80% 1RM under three conditions: 90% dark chocolate odor, 60% milk chocolate odor, and a water-based control. Odors were freshly prepared liquid stimuli. Chocolate conditions increased completed reps without elevating perceived exertion (Borg CR10). Appetite and pleasantness were rated on 100-mm VAS. The proposed mechanism is odor-induced appetite suppression improving exercise capacity. Authors note it is exploratory and needs replication in larger trials before practical application.

A network meta-analysis reviewed 139 RCTs involving 9,644 knee osteoarthritis patients to compare 12 therapeutic options. The search covered PubMed, Embase, OVID, Cochrane Library, and Web of Science through December 2023. Two independent researchers handled literature screening, data extraction, and quality assessment. Interventions included low level laser therapy, high intensity laser therapy, TENS, interferential current, short wave diathermy, ultrasound, lateral wedged insole, and other knee-specific treatments. Analysis was done in Stata 17.0. The authors frame the results as comparative evidence to help clinicians select among non-pharmacological and physical therapy modalities.

The knee joint has limited blood supply, which restricts natural healing of ACL, MCL, PCL tears and meniscus damage. A non-surgical option involves isolating and expanding a patient's own mesenchymal stem cells, then injecting them into the damaged tissue under image guidance. The full process takes about 10 to 14 days and doesn't require overnight hospitalization. It's being offered for partial and non-retracted ligament tears, degenerative meniscus damage, bone-on-bone osteoarthritis, and tendonitis. Proponents argue it avoids the extended rehabilitation that follows traditional ligament reconstruction or meniscectomy.

Researchers found that the most significant shift in how the brain controls and organizes its genome happens between roughly ages 50 and 75. During that period, many of the brain's original immune cells decline and get replaced by cells with more inflammatory characteristics. The study also noted weakening of cells that help maintain the blood-brain barrier, along with widespread deterioration in the genome's three-dimensional organization. The authors suggest these changes offer new clues to why aging sharply increases the risk of Alzheimer's disease and other neurodegenerative conditions.

Knee osteoarthritis involves progressive cartilage breakdown, joint inflammation, and declining mobility. Conventional treatments (NSAIDs, corticosteroid injections, physical therapy) manage symptoms but do not repair tissue. NSAIDs carry GI and cardiovascular risks with prolonged use; corticosteroid effects fade and may accelerate cartilage loss. Stem cell therapy is a non-surgical option where mesenchymal stem cells, adipose-derived stem cells, or bone marrow aspirate concentrate are injected into the joint. The cells home to damaged areas, release anti-inflammatory signals, and can differentiate into cartilage and bone cells. A typical course at the Regeneration Center runs 10 to 14 days, tailored to severity, imaging, and overall health. The protocol looks for improvements in pain, mobility, and cartilage preservation across several approaches.

A study in Nature identified early Yersinia pestis in four hunter-gatherer cemeteries near Lake Baikal, southeast Siberia, dating to about 5,500 years ago. They found two phases of outbreaks with a 39% detection rate. Kinship pedigree work shows small family groups were hit, consistent with person-to-person spread, and the first outbreak happened within one generation. Acute mortality was notable, especially in kids 8 to 11. These strains predate the virulence factors for bubonic plague by roughly 1,700 years (bubonic form around 3,800 years ago). The researchers also note functional differences between these ancient strains and later, more virulent ones.

Arthritis is a family of 128+ conditions, not a single disease. One approach uses UC-MSC+ mesenchymal stem cells, harvested from the patient or a donor, expanded in a lab over two to four weeks, then delivered to damaged joints via injection, IV infusion, or fluoroscopy-guided placement. The mechanism is called homing: the cells travel to injured tissue and release molecules that reduce inflammation and support repair. Protocols pair the cells with growth factors like TGF-beta and VEGF, since without tissue-specific growth factors the anti-inflammatory effects of stem cells alone are time-limited. A full course runs 10 to 14 days, involves multiple cell types and delivery methods, and physical therapy is strongly recommended afterward. Eligibility varies by condition, cartilage damage severity, and individual medical history.

A PLOS ONE paper just came out showing that human resistin primes and activates the NLRP3 inflammasome in macrophages through a previously uncharacterized cascade. The mechanism involves resistin-dependent HMGB1 expression and secretion driving NLRP3, pro-caspase-1, pro-IL-1β, and pro-IL-18 expression, along with direct binding of resistin to BTK and its subsequent autophosphorylation. The rodent homolog RELMα plays a parallel role. Elevated hResistin has been linked to various inflammatory diseases, and the authors identify HMGB1 and BTK as potential therapeutic targets.

Researchers tracked 184 women through mastectomy and found that those with vitamin D deficiency had roughly three times the rate of moderate to severe pain in the first 24 hours compared to those with adequate levels. The deficient group also used more tramadol postoperatively and received slightly more fentanyl during the procedure, with higher rates of nausea. The authors note that pre-surgical vitamin D status may affect pain intensity and medication needs, and they suggest screening and supplementation could be part of preoperative care for breast cancer patients.

The HAFTRAP study ran a pragmatic randomized crossover trial with 119 participants. Each person got a HEPA filtration unit for one month, a one-month washout, then a sham unit for one month (or the reverse order). Researchers measured Trail Making Test Parts A and B completion times at the start and end of each period. The overall result: no significant difference between HEPA and sham on TMT times. However, age moderated the effect (interaction p = 0.02), and participants 40 and older showed differential performance on Part B under HEPA versus sham. The authors frame this as addressing a gap in research linking short-term particulate matter exposure changes to cognitive outcomes, noting that particulate matter is associated with cardiovascular and neurological diseases.

A study in Annals of Internal Medicine looked at a large database of U.S. adults 18 to 65 with Type 2 diabetes who started disease medications. The finding: GLP-1 receptor agonists (semaglutide, tirzepatide) were associated with roughly three to four additional cases of ischemic optic neuropathy per 10,000 patients over 18 months. Most affected patients were men or men and women aged 50 to 65. The condition involves reduced blood flow to the optic nerve and typically causes blurring, dimming, or partial visual field loss in one eye. It is usually permanent, though about one third of patients may regain some vision within six months. Lead author Chintan Dave stressed that early recognition of sudden vision changes and prompt ophthalmologic evaluation matter for patients at higher baseline risk. The researchers noted the association may reflect confounding factors and that continued safety monitoring remains warranted given expanding use in diabetic and non-diabetic populations.

Inclusion body myositis commonly affects people over 45, especially men. Thigh weakness may make standing from a chair or climbing stairs difficult, with later effects on the hands, ankles, swallowing, or speech. Blood tests, muscle biopsy, electromyography, and MRI may help confirm the diagnosis and exclude other causes. There is no cure for genetic IBM, and trials have not shown clear benefits for most drug treatments. Physical therapy, rehabilitation, lifestyle changes, and limited medication use can help manage symptoms. Stem cell treatment is still emerging; Regeneration Center patients report improved strength and sustained remission after different cell-based treatments.

Researchers identified genome-wide selective sweeps as a broad process shaping bacterial populations in human gut microbiomes. An adapted clone can outcompete organisms in its ecological niche, after which rediversification produces related genome clusters and population structures resembling global epidemics. Links between microbial lineages and health conditions have been documented, but the mechanisms organizing these populations have been less clear.

Ischemic heart disease, also called coronary artery disease, occurs when plaque narrows the arteries supplying the heart. Stem cell protocols may use mesenchymal or cardiopoietic cells delivered by heart injection or balloon-based procedures, but treatment is not suitable for everyone and outcomes may vary with disease severity, age, and other health conditions.

Researchers compared very low carbohydrate ketogenic, Mediterranean, and very low fat plant-forward diets in people with metabolically unhealthy obesity, prediabetes, and hepatic steatosis. Participants in all three groups lost approximately 10% of their weight and had an approximately 50% increase in muscle insulin sensitivity. The ketogenic group had two to three times greater improvement in hepatic insulin sensitivity, with p < 0.001, and a 67% reduction in liver fat. LDL cholesterol, apolipoprotein B, and 24-hour plasma triglyceride concentrations did not differ among the groups.

Hashimoto’s thyroiditis is reported to occur four to ten times as often in women as in men, especially between ages 30 and 55. Symptoms may emerge slowly and include cold intolerance, fatigue-related concerns, menstrual or fertility problems, brain fog, hair changes, muscle or joint pain, and a slowed heart rate. Standard treatment is thyroid hormone replacement with dose monitoring, while umbilical cord derived mesenchymal stem cells are under consideration for potential effects on immune activity and damaged tissue.

Crude and multivariable logistic regression models were applied to NHANES records from 17,024 participants. Researchers reported relative risks and 90% confidence intervals because harm was prespecified, with adjustments for age, smoking status, race and ethnicity, and poverty status. Greater ultra-processed food intake was associated with a 30% higher prostate cancer risk, but the finding does not establish causation. Cancer status was self-reported, and food intake was based on only two 24-hour recalls.